2020 Focused Updates to the Asthma Management Guidelines: Intermittent Inhaled Corticosteroids
CHOC is pleased to introduce our Virtual Pediatric Lecture Series. This series is part of our continued commitment to bring the latest, most relevant medical news to community providers. All sessions, unless otherwise noted, are eligible for CME credit.
Date: Wednesday, June 7, 2023
Time: 12:30 – 1:30 PM (PDT)
Target Audience: General pediatricians, family practitioners and other healthcare providers
Presenter: Dr. Pornchai Tirakitsoontorn, Pediatric Pulmonology, CHOC Specialists
Topic: 2020 Focused Updates to the Asthma Management Guidelines: Intermittent Inhaled Corticosteroids
After this lecture the healthcare professional should be able to manage:
- Children 0-4 years with recurrent wheezing triggered by viral URI.
- Children 4 years and older with moderate to severe persistent asthma with SMART therapy as preferred treatment for step 3 or 4 therapy.
- Children 12 years and older with mild persistent asthma with as needed inhaled corticosteroid (ICS) and short acting beta2-agonist (SABA).
Accreditation CHOC is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.
CHOC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in this live activity.
Nursing CEs: Continuing Medical Education is also acceptable for meeting RN continuing education requirements, as long as the course is Category 1 and has been taken within the appropriate time frames.
Questions: Please contact CHOC Business Development at 714-509-4291, or BDINFO@choc.org